StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Sunday morning. The firm issued a sell rating on the stock.
Navidea Biopharmaceuticals Price Performance
Shares of NYSE:NAVB opened at $0.04 on Friday. Navidea Biopharmaceuticals has a 1-year low of $0.02 and a 1-year high of $0.28. The business has a fifty day moving average price of $0.04 and a 200-day moving average price of $0.05. The company has a market capitalization of $3.68 million, a PE ratio of -0.61 and a beta of 1.13.
About Navidea Biopharmaceuticals
Read More
- Five stocks we like better than Navidea Biopharmaceuticals
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Charles Schwab Fortifies its Uptrend on EPS Beat
- Where Do I Find 52-Week Highs and Lows?
- Lockheed Martin Stock Aims for a Fresh All-Time High
- The Most Important Warren Buffett Stock for Investors: His Own
- Beyond the Halving: The Future of Bitcoin Mining Stocks
Receive News & Ratings for Navidea Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Navidea Biopharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.